A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer

被引：0
|
作者：
Birch, R
Weaver, CH
Hainsworth, JD
Bobo, C
Greco, FA
机构：
[1] RESPONSE ONCOL INC, 1775 MORIAH WOODS BLVD, MEMPHIS, TN 38117 USA
[2] SARAH CANNON CANC CTR, NASHVILLE, TN USA
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 137
页数：3
相关论文
共 50 条
  • [1] Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer
    Greco, FA
    Hainsworth, JD
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 7 - 10
  • [2] Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer
    Reck, M
    von Pawel, J
    Macha, HN
    Kaukel, E
    Deppermann, KM
    Bonnet, R
    Ulm, K
    Hessler, S
    Gatzemeier, U
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) : 1118 - 1127
  • [3] Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma
    Hainsworth, JD
    Stroup, SL
    Greco, FA
    CANCER, 1996, 77 (12) : 2458 - 2463
  • [4] Concomitant chemotherapy paclitaxel, carboplatin, etoposide and radiotherapy in the treatment of advanced non small cell lung cancer
    Kaplanova, J
    Tomiskova, M
    Babickova, L
    Kubova, O
    Skrickova, J
    Svobodnik, A
    Koptikova, J
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 225 - 227
  • [5] Treatment of non small cell lung cancer with Paclitaxel/Carboplatin
    Budinger, M
    Klein, H
    Welte, T
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 481 - 485
  • [6] Ifosfamide, etoposide, Carboplatin and cisplatin in the treatment of small cell lung cancer
    Mahjoubi, R
    Llory, JF
    Brugiere, O
    Vannetzel, JM
    ANNALS OF ONCOLOGY, 1998, 9 : 105 - 105
  • [7] Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer
    Langer, Corey J.
    Albert, Istvan
    Ross, Helen J.
    Kovacs, Peter
    Blakely, L. Johnetta
    Pajkos, Gabor
    Somfay, Attila
    Zatloukal, Petr
    Kazarnowicz, Andrzei
    Moezi, Mehdi M.
    Schreeder, Marshall T.
    Schnyder, Judy
    Ao-Baslock, Ada
    Pathak, Ashutosh K.
    Berger, Mark S.
    LUNG CANCER, 2014, 85 (03) : 420 - 428
  • [8] Paclitaxel/carboplatin in the treatment of non-small-cell lung cancer
    Belani, CP
    ONCOLOGY-NEW YORK, 1998, 12 (01): : 74 - 79
  • [9] A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
    Paz-Ares, Luis
    Balint, Beatrix
    de Boer, Richard H.
    van Meerbeeck, Jan P.
    Wierzbicki, Rafal
    De Souza, Paul
    Galimi, Francesco
    Haddad, Vincent
    Sabin, Tony
    Hei, Yong-jiang
    Pan, Yang
    Cottrell, Susan
    Hsu, Cheng-Pang
    RamLau, Rodryg
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 329 - 337
  • [10] A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer
    Salgia, Ravi
    Stille, John R.
    Weaver, R. Waide
    McCleod, Michael
    Hamid, Oday
    Polzer, John
    Roberson, Stephanie
    Flynt, Amy
    Spigel, David R.
    LUNG CANCER, 2017, 105 : 7 - 13
12345